Advisor Group’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-230
Closed -$1K 5469
2019
Q1
$1K Buy
230
+65
+39% +$753 ﹤0.01% 5158
2018
Q4
$2K Hold
165
﹤0.01% 4879
2018
Q3
$3K Buy
165
+104
+170% +$1.97K ﹤0.01% 4788
2018
Q2
$1K Hold
61
﹤0.01% 4869
2018
Q1
$1K Sell
61
-27
-31% -$533 ﹤0.01% 4890
2017
Q4
$2K Sell
88
-113
-56% -$1.56K ﹤0.01% 4741
2017
Q3
$3K Sell
201
-54
-21% -$848 ﹤0.01% 4475
2017
Q2
$4K Sell
255
-49
-16% -$852 ﹤0.01% 4359
2017
Q1
$5K Buy
304
+157
+107% +$3.13K ﹤0.01% 4144
2016
Q4
$3K Buy
+147
New +$3.02K ﹤0.01% 4158

Other funds holding ARA

Advisor Group's ARA Position: Q2 2019 in Review

Advisor Group sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2019, closing a stake of 230 shares — an estimated $1K sold.

Advisor Group first reported a position in ARA in Q4 2016 and held it in 10 quarters. The position peaked at $5K in Q1 2017. 67 funds tracked by Wall St. Rank hold ARA as of Q2 2019.

  • Advisor Group reported no remaining American Renal Associates Holdings, Inc position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 230 American Renal Associates Holdings, Inc shares in Q2 2019, an estimated $1K.
  • Advisor Group first reported a position in American Renal Associates Holdings, Inc in Q4 2016 and held it in 10 quarters.
  • Advisor Group's American Renal Associates Holdings, Inc position peaked at $5K in Q1 2017.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.